Abstract | CONTEXT: Mutations of the beta-catenin (CTNNB1) gene are frequently found in adrenocortical tumors. This has important consequences to deregulate the expression of transcriptional targets of the Wnt pathway, which may contribute to tumorigenesis. OBJECTIVE: The objective of the study was to investigate the effect of the small-molecule inhibitor of the T cell factor (Tcf)/ beta-catenin complex PKF115-584 on beta-catenin-dependent transcription and proliferation of H295R adrenocortical tumor cells, which harbor mutations in CTNNB1 as well as the TP53 tumor suppressor gene. MAIN OUTCOME MEASURES: Immunofluorescence, transient transfection, proliferation assays, and flow cytometric analyses were used. RESULTS: Nuclear localization of beta-catenin and constitutive activation of beta-catenin-dependent transcription was observed in H295R cells. PKF115-584 dose-dependently inhibited beta-catenin-dependent transcription and H295R proliferation, even in the presence of increased steroidogenic factor-1 levels, which augment proliferation in this cell line. The drug had no effect on HeLa cells, a cell line in which the beta-catenin pathway is not activated. PKF115-584 decreased the percentage of H295R cells in S-phase and increased the percentage of apoptotic cells. CONCLUSIONS: Inhibitors of the Tcf/ beta-catenin complex may prove useful in the treatment of adrenocortical tumors in which multiple genetic alterations have accumulated.
|
Authors | Mabrouka Doghman, Julie Cazareth, Enzo Lalli |
Journal | The Journal of clinical endocrinology and metabolism
(J Clin Endocrinol Metab)
Vol. 93
Issue 8
Pg. 3222-5
(Aug 2008)
ISSN: 0021-972X [Print] United States |
PMID | 18544621
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- TCF Transcription Factors
- beta Catenin
|
Topics |
- Adrenal Cortex Neoplasms
(drug therapy, genetics, pathology)
- Cell Proliferation
(drug effects)
- Genes, p53
- Humans
- Mutation
- TCF Transcription Factors
(antagonists & inhibitors)
- Tumor Cells, Cultured
- beta Catenin
(antagonists & inhibitors, genetics)
|